Regression of Cardiac Rhabdomyomas in a Neonate after Everolimus Treatment

@inproceedings{Bornaun2016RegressionOC,
  title={Regression of Cardiac Rhabdomyomas in a Neonate after Everolimus Treatment},
  author={Helen Aghdasi Bornaun and Kazım {\"O}ztarhan and Tuğba Erener-Ercan and Reyhan Dedeoğlu and Deniz Tuğcu and Cigdem Yilmaz Aydogmus and Merih Çetinkaya and Sultan Kavuncuoğlu},
  booktitle={Case reports in pediatrics},
  year={2016}
}
Cardiac rhabdomyoma often shows spontaneous regression and usually requires only close follow-up. However, patients with symptomatic inoperable rhabdomyomas may be candidates for everolimus treatment. Our patient had multiple inoperable cardiac rhabdomyomas causing serious left ventricle outflow-tract obstruction that showed a dramatic reduction in the size after everolimus therapy, a mammalian target of rapamycin (mTOR) inhibitor. After discontinuation of therapy, an increase in the diameter… CONTINUE READING

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
1 Extracted Citations
9 Extracted References
Similar Papers

Referenced Papers

Publications referenced by this paper.
Showing 1-9 of 9 references

Similar Papers

Loading similar papers…